VIA Versus Colposcopy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age25-65
SponsorSohag University
About this trial
The aim of this study is to compare the effectiveness of visual inspection with acetic acid (VIA) versus colposcopy in terms of sensitivity and specificity in diagnosis of pre-malignant cervical lesions among women, and to assess the awareness of women regarding cervical cancer screening methods.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age from 25 to 65 years.
Patient undergoing cervical cancer screening using VIA and colposcopy.
Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding.
Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization)
Disqualifiers
• Pregnant women (if VIA or colposcopy is contraindicated).
Women with obvious invasive cervical cancer diagnosed previously.
Women who refuse to provide informed consent or are unable to cooperate with the examination.
Women having active vaginal bleeding.
Trial population
outpatient clinic pateints
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
VIA
Other interventionA 5% acetic acid solution will be applied to the cervix, and after one minute, the cervix will be inspected under adequate light
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
VIA Versus Colposcopy in terms of in terms of sensitivity and specificity
Patients will be observed for any immediate discomfort or minor complications such as spotting, mild cramping, or vaginal irritation following VIA, colposcopy, or biopsy. All patients will be advised on post-procedure care, including avoiding vaginal do
Time frame
2 weeks2
sensitivity and specificity in diagnosis of pre-malignant cervical lesions among women
Patients will be observed for any immediate discomfort or minor complications such as spotting, mild cramping, or vaginal irritation following VIA, colposcopy, or biopsy. All patients will be advised on post-procedure care, including avoiding vaginal douching, sexual activity, or use of tampons for a few days, if a biopsy will be performed. Results of the VIA, colposcopy, and histopathology will be explained to the patients, and appropriate follow-up or referral will be arranged for those with CIN 2, CIN 3, or carcinoma. Patients will be instructed to report any unusual bleeding, pain, or discharge immediately to the clinic.
Time frame
From enrollment to the the result at 14 daysLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: